Hannah Sur

Mount Sinai Hospital

Papers

1

Total Citations

8

H-Index

1

About

Dr. Hannah Sur is a rising leader in urologic surgery, whose work is reshaping the surgical management of benign prostatic hyperplasia (BPH). Her research focuses on comparing the efficacy and safety of advanced, minimally invasive techniques for prostate surgery. In her landmark 2024 study, Dr. Sur conducted a rigorous propensity-matched analysis comparing en-bloc Holmium Laser Enucleation of the Prostate (HoLEP) with early apical release against transvesical Robot-Assisted Simple Prostatectomy (RASP). This work, which has already garnered 8 citations shortly after publication, provides critical, evidence-based guidance for surgeons choosing between these two leading procedures for medication-refractory BPH. By meticulously evaluating outcomes, Dr. Sur’s contributions help to define best practices, reduce surgical complications, and improve recovery for patients. Her dedication to comparative effectiveness research positions her as a key voice in the evolution of urologic surgery, offering clear data to inform clinical decision-making in a rapidly advancing field.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Comparative Outcomes of En-Bloc Holmium Laser Enucleation of the Prostate and Transvesical Robot-Assisted Simple Prostatectomy for the Management of Benign Prostatic Hyperplasia: A Propensity-Matched Analysis
8 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Mount Sinai Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago